
Elanco CREDELIO PLUS 22-45 kg Tablets №3
✓ In stockProduct code: 36780
Pet size:22-45 kg
Quantity:3 pcs
- Brand
- Credelio
- Pharmacological group
- Medicines for ticks and parasites, From ticks and fleas, From worms
- Product form
- Pills
- Quantity
- 3 pcs
- Barcode
- 5420036941194
- Size
- 22-45 kg
- Product type
- Antiparasitic agents
- Animal
- For dogs
- Brand registration country
- France
Antiparasitic chewable tablets for dogs weighing 22-45 kg Elanco CREDELIO PLUS Credelio Plus against fleas, ticks, helminths, 3 pcs.
Credelio PLUS Antiparasitic Chews for Dogs Weighing 22 to 45kg (Pack of 3)
Protect your beloved pet from a wide range of parasites with Credelio PLUS Antiparasitic Chews from Elanco. This effective product provides comprehensive protection against fleas, ticks and heartworms, providing up to 12 weeks of long-lasting action against each type of parasite.
Superior parasite protection
- Kills fleas within 4 hours, preventing infestation and itching
- Kills all types of ticks, including those that can transmit Lyme disease and ehrlichiosis
- Controls intestinal helminths, including roundworms and tapeworms
Easy to use
- Tasty, meat-flavored chewable tablets are attractive to dogs and easy to take
- No monthly dosing required, avoiding missed doses
- Can be used for dogs 8 weeks of age and older, weighing 22 to 45 kg
Safe and effective
- FDA approved for use in dogs
- Does not contain avermectins, making it safe for dogs with neurotoxin sensitivities
- Clinically proven effective against all major types of parasites affecting dogs
Ingredients:
- Lotilaner 452 mg (Credelio)
- Milbemycin oxime 12.5 mg
- Fosfomycin 62.5 mg
Dosage:
One chewable tablet based on dog's weight every 12 weeks.
Benefits:
- Comprehensive protection against fleas, ticks and heartworms
- Long lasting for up to 12 weeks
- Easy to use with tasty chewable tablets
- Safe for dogs 8 weeks of age and older, Weighing 22 to 45 kg
*FDA approved and clinically proven effective
Reviews
No reviews yet
Be the first to review this product.














